Client News
Apogenix’ partner CANbridge announces 67 % five-year overall survival rate compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients
27th March 2023
Destiny Pharma announces publication of XF-73 nasal gel Phase 2 data in leading US journal Infection Control & Hospital Epidemiology
24th March 2023
Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
24th March 2023
A new prestigious scientific publication for Carbios marks the expansion of its research to other plastics
21st March 2023
Mainz Biomed to present at Sidoti Virtual Investor Conference March 22-23
21st March 2023
Rentschler Biopharma’s service excellence recognized with CDMO Leadership Awards and Champion status
20th March 2023
Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
20th March 2023
Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure
15th March 2023
Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
15th March 2023
There is no more content to load